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Sox9Epithelial–mesenchymal transition (EMT) permits neural crest cells to delaminate from the epithelial
ectoderm and to migrate extensively in the embryonic environment. In this study, we have identiﬁed ATF4, a
basic-leucine-zipper transcription factor, as one of the neural crest EMT regulators. Although ATF4 alone was
not sufﬁcient to drive the formation of migratory neural crest cells, ATF4 cooperated with Sox9 to induce
neural crest EMT by controlling the expression of cell–cell and cell–extracellular matrix adhesion molecules.
This was likely, at least in part, by inducing the expression of Foxd3, which encodes another neural crest
transcription factor. We also found that the ATF4 protein level was strictly regulated by proteasomal
degradation and p300-mediated stabilization, allowing ATF4 protein to accumulate in the nuclei of neural
crest cells undergoing EMT. Thus, our results emphasize the importance of the regulation of protein stability
in the neural crest EMT.Advanced Animal Research on
science, Graduate School of
Japan. fax: +81 22 717 8205.
Y. Wakamatsu).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Epithelial–mesenchymal transition (EMT) is an important process
in the tissue morphogenesis and organogenesis to generate motile
cells (Acloque et al., 2009; Kalluri and Weeinberg, 2009 for reviews).
During EMT, epithelial cells lose tight cell–cell adhesion, remodel their
cytoskeleton so as to lose apicobasal polarity, degrade the basal
membrane, and increase the association with the extracellular matrix.
The neural crest is one of the model systems to study EMT in
development. The neural crest is initially induced at the boundary of
neural plate and non-neural ectoderm in vertebrate embryos by BMP
and Wnt signalings (Kalcheim and Burstyn-Cohen, 2005; Sakai and
Wakamatsu, 2005; Sauka-Spengler and Bronner-Fraser, 2008 for
reviews), and crest cells subsequently undergo EMT. Highly motile
crest cells eventually give rise to various tissues including neurons,
glial cells, melanocytes, and cranial mesenchymal tissues in distinct
locations (Le Douarin and Kalcheim, 1999).
In recent years, several transcription factors have been identiﬁed
as important regulators of the neural crest EMT. Group E Sox genes
such as Sox8, 9, and 10, which encode HMG-box transcription factors,
appear to be important for formation of neural crest cells. Inparticular, Sox9 seems to be essential for the regulation of EMT both
in mouse and in chick (Cheung and Briscoe, 2003; Cheung et al., 2005;
Sakai et al. 2006). Another EMT-related transcription factor gene,
Snail2, is also essential for the neural crest EMT in avian embryos
(Neito et al., 1994; Sakai et al, 2006), and Sox9 directly activates the
transcription of Snail2 (Sakai et al., 2006). Foxd3, a zinc-ﬁnger
transcription factor gene, is also involved in the neural crest EMT
phenotype (Dottori et al., 2001; Cheung et al., 2005). Thus,
misexpression of Foxd3 in the neural tube results in the induction of
neural crest markers and in the reduction of N-cadherin and the
induction of Integrin-β1(Cheung et al., 2005), but no (Kos et al., 2001;
Suzuki et al., 2006) or limited (Dottori et al., 2001) induction of EMT
was observed. Cotransfection experiments revealed that the combi-
nation of such transcription factors, Sox9, Snail2, and Foxd3, effectively
induces ectopic EMT, alongwith other traits of neural crest cells, in the
transfected neural tube (Cheung et al., 2005).
Posttranslational modiﬁcations of these transcription factors
appear to be deeply involved in the neural crest development. For
example, SOMOylation of Xenopus Sox9 modulates its function in
neural crest induction and following differentiation (Taylor and
LaBonne, 2006). Direct phosphorylation by PKA is essential for chick
Sox9 to promote EMT, although this phosphorylation of Sox9 is not
required for the activation of Snail2 transcription (Sakai et al.,
2006). Ubiquitination of Xenopus Snail2 by Ppa/Fbxl-14, one of the
target-recognition subunits of Skp1-CDC53/Cullin-1-F-box protein
(SCF) complex, limits the Snail2 protein level via proteasomal
degradation (Vernon and LaBonne, 2006). Consistently, Xenopus
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domain in the embryonic ectoderm (Voigt and Papalopulu, 2005).
In this study, we focus on the function of Activation transcription
factor 4 (ATF4, also known as TAXCREB67, CREB-2, mTR67, and C/ATF.
See Ameri and Harris, 2008 for nomenclatures.), which appears to be
expressed at high levels in the neural folds and the migrating neural
crest cells of mouse embryos at least at the mRNA level (Murphy and
Kolstø, 2000). ATF4 gene encodes a basic-leucine-zipper-type tran-
scription factor of the ATF/Creb family (Hai and Hartman, 2001, for a
review). Numerous reports revealed the ATF4 functions, such as
modulation of metabolic and oxidative stress, regulations of eye
development, hematopoiesis, bone morphogenesis, fertility, long-
term memory storage, and synaptic plasticity (Ameri and Harris,
2008, for a review), but no function in neural crest development has
been reported so far.
In this study, we have identiﬁed an avian homolog of ATF4,
generated by an anti-ATF4 antibody, and found the ATF4 protein
rapidly accumulates in the neural crest cells undergoing EMT.
Subsequently, our gain- and loss-of-function experiments revealed
that ATF4 is one of the EMT regulating components of neural crest
cells. We also show that the nuclear accumulation of ATF4 protein is




Japanese quail (Coturnix japonica) eggs were obtained from Sendai
Jun-ran, Sendai. Embryos were staged according to Hamburger and
Hamilton (1951; HH stage).
In situ hybridization
Whole-mount and section in situ hybridizations were performed as
described previously (Wakamatsu and Weston, 1997). The coding
sequences of quail ATF4 and p300 were PCR-ampliﬁed from oligo (dT)
primed E2 embryo cDNA pool, and were subcloned into pBluescriptII
(Stratagene). The identity of avian ATF4 cDNA was conﬁrmed by an
amino acid sequence comparisonwith CREB, ATF4, and ATF5 sequences
of other species (see Supplemental Figure 1). The sequences of primers
were as follows: ATF4F, GGAAGACACTGGTGATCTCC, ATF4R, CTACT-
CAGGGACTCTAGCTC; p300F, ATCCTCAGGCACAGCAGATG, p300R,
CTAGTGTATGTCTAGTGTAC. Quail Snail2, Sox2, Sox9, and chicken Sox10
cDNAs for cRNA probes were described previously (Cheng et al., 2000;
Endo et al., 2002; Wakamatsu et al., 2004; Sakai et al., 2006). Chicken
cDNAs of Foxd3 (Kos et al., 2001), Integrin-β1 (Cao et al., 2007), N-
cadherin (Matsumata et al., 2005), Cadherin7 and Cadherin6B
(Nakagawa and Takeichi, 1995) were kind gift from Drs. C. Erickson, F.
Gage, M. Uchikawa, and S. Nakagawa, respectively.
Antibodies and immunostaining
Anti-quail ATF4 polyclonal antiserum was raised by immunizing
rabbits with a GST-tagged recombinant quail ATF4 protein (aa 1–296,
ATF4ΔC). Thus, the corresponding ATF4 sequence was inserted into
pET41a (Novagen) for GST-fusion and bacterial expression. Recombi-
nant GST-ATF4 fusion protein was puriﬁed from bacterial lysates with
B-PER GST-fusion protein puriﬁcation kit (Pierce). HNK1 mouse IgM
and anti-Pax6 rabbit antibodies were described previously (Tucker
et al., 1988; Inoue et al., 2000). PAX7 anti-Pax7, 3H11 anti-Laminin,
and 6B3 anti-N-cadherin mouse IgG antibodies were obtained from
Developmental Study Hybridoma Bank (University of Iowa). M2 anti-
FLAG (mouse IgG1; Sigma), anti-GFP (rabbit polyclonal; Chemicon),
12CA5 anti-HA (mouse IgG; Roche), anti-ZO1 (rabbit polyclonal;
Zymed), N15 anti-p300 (rabbit polyclonal; Santa Cruz), anti-phos-pho-Histone H3 (rabbit polyclonal; Upstate), and anti-active caspase
3 (rabbit monoclonal; BD Pharmingen) antibodies were commercially
obtained. T8-754 anti-ZO1 mouse IgG was kindly provided by Dr. M.
Furuse (Kitajiri et al., 2004). Fluorochrome-conjugated secondary
antibodies were purchased from Jackson Immuno Research. Phalloi-
din conjugated with Texas Red-X or Oregon Green was obtained from
Molecular Probes.
Immunological staining on sections and cultured cells was
performed as described previously (Wakamatsu et al., 1993, 1997).
Immunostaining for ATF4 and p300 required a short ﬁxation
condition (in 4% paraformaldehyde/PBS for 30 min at 4 °C). Sections
treated with antibodies were also exposed to DAPI (Sigma) to
visualize nuclei.Expression vectors
PCR-ampliﬁed coding sequences of quail ATF4 and p300 were
inserted into expression vectors pyDF30 and pyDF-HA for N-terminal
FLAG andHA tagging, respectively. Substitutions ofβ-TrCP1 binding site
(aspartic acid218 and serine219) to alanineand thenuclear localization
signal (lysine 281, 282, 284, 285; Cibeli et al., 1999) to asparagine were
introduced towild type ATF4 sequence by using in vitromutagenesis kit
(Stratagene). For generating a repressor form of ATF4 (En-ATF4ΔN),
recombinant PCR was performed to generate N-terminal deletion of
ATF4 cDNA lacking the corresponding sequence (aa 1–180), and the
deletionmutant cDNAwas subsequently fused to the repressiondomain
of Engrailed2 (a gift from Dr. H. Nakamura; Matsunaga et al., 2000) to
construct pyDF-HA-En-ATF4ΔN. The dominant-negative action of En-
ATF4ΔN was conﬁrmed by the fact that the transcriptional activation of
pCRE-luc, a Luciferase reporter gene under the control of cAMP
responsive element (Clontech), was activated by wild type ATF4, and
that En-ATF4ΔN cotransfection attenuated the activation (Supplemental
Figure 2). An expression vector of quail Sox9 was previously described
(Sakai et al., 2006).GFP-tagged chicken Foxd3 expression construct (Kos
et al., 2001) was kindly provided by C. Erickson, and GFP-tag was
removed (pyDF-HA-Foxd3). Expression of these transgenes was con-
ﬁrmed by immunostaining of transfected cells by anti-epitope tag
antibodies and/or Western blotting (data not shown). pEGFP-N1 was
purchased from Clontech. When HA-tagged ATF4 was transfected into
the neural tube along with pEGFP-N1, more than 70% of EGFP-positive
cells coexpressed HA-ATF4 protein in their nuclei, revealed by
immunostaining of sections. In contrast, only 17% of EGFP-positive
cells coexpressed FLAG-tagged ATF4 protein, when cotransfected (see
text and Fig. 6). Thus, for studying the misexpression phenotype, HA-
tagged ATF4 vector was used, while for testing the protein expression
efﬁciency, FLAG-tagged versions were used. In addition, FLAG-tagged
ATF4 cDNAs were subcloned into pCMS-EGFP dual promoter vector
(Clontech) to ensure coexpression of EGFP and ATF4 transgenes in
individual transfected cell.Neural plate explant culture
Cultures of neural plate explants were performed as described
previously (Wakamatsu et al., 2004, Sakai et al., 2005). In brief,
intermediate fragments of the neural plate at the level of forebrain
and midbrain were surgically dissected with a tungsten needle along
with underlying mesoderm and endoderm. To remove the mesoderm
and the endoderm, the dissected tissues were treated with Pancreatin
(Wako). The isolated neural plates were cultured in F12-based
medium containing 3% FCS on ﬁbronectin (Sigma)-coated dishes.
N2-supplement (1:100 dilution, Invitrogen) and recombinant human
BMP4 (20 ng/ml; R&D Systems) were added in culture to induce
neural crest formation. Tenmicromolars of MG132 (Wako)was added
in culture as a proteasome inhibitor, when indicated.
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Electroporations into the neural tube of E2 embryos and into the
neural plate of stage 7 embryos for explant culture were performed as
previously described (Funahashi et al., 1999; Wakamatsu et al., 2004;
Sakai et al., 2005, 2006).
Whole-embryo culture in combination with electroporation was
described previously (Endo et al., 2002, 2003, Sakai et al., 2005). In
brief, before electroporation, the embryos adhering to collagen-coated
membranes were set on a chamber with a 2-mm2 positive electrode
(Unique Medical Imada). A tungsten needle was used as the negative
electrode. DNA solution (1.2 μl of 5 μg/μl in PBS containing 0.025% Fast
Green)was placed on the right ectoderm of the embryo. The condition
of electroporation was as follows: 7 V, 25 ms in duration, 200 ms
interval, and three times. For cotransfection studies, pEGFP-N1 and
another expression vector were mixed at 1:1. For each experiment,
3 to 10 transfected embryos were examined, and only when at least
two-thirds of examined embryos were similarly affected, the
observed changes were identiﬁed as phenotypes.Results
ATF4 protein rapidly accumulates in neural crest nuclei during EMT
First, we have examined ATF4 mRNA expression in the early quail
embryos by in situ hybridization. Tissue distribution of avian ATF4
mRNA resembled that of the mouse homolog (Murphy and Kolstø,
2000), and elevated expression was conﬁrmed in the neural folds,
which overlapped with the expression of Snail2 in premigratory crest
cells (Figs. 1A, B, D, and E). ATF4 expression was also detected in
migrating cranial neural crest cells (Fig. 1C).
To observe ATF4 protein expression, polyclonal anti-ATF4 antibody
was raised in a rabbit (seeMaterials andmethods). At stage 8, before theFig. 1. Expression of ATF4mRNA in the cranial neural crest. Whole-mount dorsal view of
HH stage 7, 8, 9 quail embryos (A–C), and neighboring transverse sections of stage
8 embryo (D and E). An elevation of ATF4 expression is observed in the neural folds (A
and B, arrowheads). ATF4 mRNA is also detected in migrating cranial crest cells (C′,
arrowheads). Higher expression of ATF4 is observed in the neural crest cells (D,
arrowhead), which are positive for Snail2 (E, arrowhead).EMT of cranial neural crest cells, ATF4 proteinwas detected in a fraction
of Pax7-positive prospective neural crest cells (Figs. 2A, B, and I–K). At
stage 8.5, when many crest cells were actively undergoing EMT, ATF4
protein accumulation in the nuclei was observed in many, if not all, the
Pax7-positive crest cells (Figs. 2C and D). Interestingly, the neural tube
cells, which did not accumulate ATF4 in their nuclei, weakly possessed
anti-ATF4-immunoreactivity in their cytoplasm (Figs. 2L–N). At stage 9,
migrating cranial crest cells expressed ATF4 protein (Figs. 2E and F).We
also examined the ATF4 immunoreactivity at the trunk level of stage 12
embryos. Thus, ATF4 protein was highly accumulated in the emerging
Pax7-positive crest cells on the top of the neural tube (Figs. 2G and H).
Among non-crest tissues, we noticed that the epidermal ectoderm cells
persistently expressed ATF4 protein at all stages and anteroposterior
levels examined in this study (Figs. 2A and E, arrows).
To clarify the timing of ATF4 nuclear accumulation, we took
advantage of neural plate explant culture system (Materials and
methods; see also Wakamatsu et al., 2004; Sakai et al., 2005, 2006).
Thus, culturing medial neural plate explants in the presence of BMP4
transformed the neural plate cells to neural crest fate. When cultured
in this condition for 16 hours, many explant cells expressed neural
crest markers (Sakai et al., 2005, 2006), and at the edge of the
explants, many cells were undergoing EMT (Figs. 2O–W). These cells
at the edge of the explant were losing cell–cell adhesion, visualized by
the lack of ZO-1 immunoreactivity, and possessed high levels of ATF4
protein in their nuclei (Figs. 2R–W), while cells in the interior of the
explant showed only weak and punctate staining for anti-ATF4
antibody in their cytoplasm (Figs. 2R–T). In 20-hour cultures, many
crest cells with ﬁbroblastic morphology and actin cytoskeleton
dispersed, and the vast majority of these migrating crest cells were
also ATF4-positive in their nuclei (approximately 95%; see Figs. 2X–Z).
These observations indicated that ATF4 protein is rapidly accumulated
in the nucleus at the onset of crest EMT.
ATF4 participates in the regulatory program of the neural crest EMT
Misexpression of ATF4 in the neural tube induces partial EMT phenotype
To examine possible roles of neural crest transcription factors in
vivo, transfection of expression vectors into the neural tube of E2
avian embryos has often been practiced (Dottori et al., 2001; Kos et al.,
2001; Cheung and Briscoe, 2003; Wakamatsu et al., 2004; Cheung et
al., 2005; McKeown et al., 2005; Suzuki et al., 2006). We thus
performed unilateral cotransfection of EGFP and HA-tagged ATF4
expression vectors and observed the phenotype 6, 12, and 24 hours
later (Figs. 3 and 4). The nuclear localization of HA–ATF4 protein was
conﬁrmed by anti-HA immunostaining (data not shown). At 6 hours,
the morphology of the ATF4-transfected neural tube was grossly
normal compared to the EGFP-transfected control neural tube
(Fig. 3A). Many transfected cells showed apicobasally elongated
shape (Fig. 3A), although actin cytoskeleton of neuroepithelial cells
seemed to be slightly irregular in ATF4-transfected neural tube
(Fig. 3A). At 12 and 24 hours, the ATF4-transfected neural tubes
became thinner compared to the contralateral side of the same
embryo or compared to control neural tubes transfected with EGFP
(Fig. 3A). While cells in EGFP-transfected neural tube remained
apicobasally polarized, many ATF4-transfected cells rounded and fell
off into the lumen of the neural tube (Fig. 3A).
Althoughwecoulddetectmanyphospho-HistoneH3(pH3)-positive
mitotic ﬁgures at all stages examined, suggesting that ATF4-transfected
cells could proliferate, these mitotic cells often failed to align along the
apical side of the neural tube (Fig. 3B). Thus, while the proportion of
such abventricular pH3-positive cells in EGFP-transfected neural tubes
was 1.3% (2/150 cells, n=3) 24 hours after transfection, that in EGFP/
ATF4-cotransfected neural tubes was 20.5% (41/200 cells, n=3). There
was also an increase of active caspase 3-positive apoptotic cells (Fig. 3B).
Thus, while the proportion of active caspase 3/EGFP double-positive
cells among EGFP-positive cells in EGFP-transfected neural tubes was
Fig. 2. Expression and cellular localization of ATF4 protein in the neural crest cells. Transverse sections of HH stage 8 (A and B), 9 (C and D), 11 (E and F), and 14 (G and H) were
double-stained with anti-ATF4 and anti-Pax7 antibodies. High levels of ATF4 protein expression are observed in Pax7-positive premigratory and migrating neural crest cells
(arrowheads). Higher magniﬁcation of A and B (I–K) reveals that some Pax7-positive cells coexpress ATF4 (arrowheads), while others are ATF4-negative (arrows). Higher
magniﬁcation of C and D (L–N) reveals that migrating crest cells possess ATF4 protein in their nuclei (arrowheads), but many cells remaining in the neural tube have weak,
cytoplasmic anti-ATF4 immunoreactivity (arrows). DAPI indicates nuclei. (O–Z) Neural plate explants were cultured in the presence of BMP4. R–T show higher magniﬁcation views
corresponding to the area indicated in O. At 16 hours of culture (O–W), ATF4 is highly accumulated in the nuclei of cells residing at the edge of the explant after (white arrowhead) or
undergoing (black arrowheads) EMT, while interior cells possess weak anti-ATF4 immunoreactivity in their cytoplasm (arrow) (R–T). U–W show a high-magniﬁcation view of the
edge of a similar explant, stained with anti-ATF4, anti-ZO-1, and DAPI. Cells losing cell–cell junction accumulates ATF4 protein in their nuclei (arrowheads). At 20 hours of culture,
dispersing crest cells are ATF4-positive in their nuclei (X–Y). Phalloidin staining of F-actin reveals mesenchymal cell morphology (Y).
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cotransfected neural tubes was 5.6% (99/1760 cells, n=3). Consistent
with the fact that no ATF4-transfected cells came out from the ectopic
position of the neural tube, basement membrane appeared to be intact
(Fig. 3B), although ATF4-transfected neural tube cells sometimes
possessed Laminin ectopically suggesting that the transfected neural
tube cells failed to exclusively target deposition of Laminin protein to
the basal surface. Thus, the thinning of the neural tube by ATF4
misexpression seemed to be caused by the combination of cell shape
change, probably by losing epithelial polarity, cell death, and detach-
ment of cells into the lumen.
The detachment of cells from their apical junctional sites at the
lumen suggested that the transfected neural tube cells might have lost
cell–cell adhesion. Thus, expression of cell–cell and cell–ECM
adhesion molecules was also examined. It has been known that the
cadherin subtype changes from N-cadherin to Cadherin6B during crest
induction, and migrating crest cells further downregulate Cadherin6B
and begin to express Cadherin7 in avian embryos (Nakagawa and
Takeichi, 1995). While no change in the expression of N-cadherin
protein was observed at 6–hours after ATF4-transfection (Figs. 4A and
B), at 12 and 24 hours, the expression of N-cadherin was clearly
decreased (Figs. 4F, G, K, and L). Consistent with the reduction of N-cadherin expression, ATF4 transfection also downregulated the
expression of Sox2 (Figs. 4H and M), an activator of N-cadherin
transcription (Matsumata et al., 2005) and an inhibitor of neural crest
formation (Wakamatsu et al., 2004). We also observed Cadherin6B
mRNA expression in the pre-EMT crest cells being diminished by ATF4
misexpression (Figs. 4P and Q). In the ATF4- transfected neural tube,
we not only observed downregulation of genes indicated above but
also detected ectopic inductions of Cadherin7, and Integrin-β1, which
is normally expressed inmigrating crest cells as a receptor for the ECM
binding (Duband et al., 1991), at all stages examined (Figs. 4D, E, I, J, N,
and O).
As indicated above, before the neural crest EMT, ATF4 protein
localized in the cytoplasm at low levels, and subsequently accumulated
in the nuclei during EMT. To ensure the observed phenotypes caused by
ATF4misexpression in theneural tubeas the effect of ATF4protein in the
nuclei, an expression vector carrying HA-ATF4 with mutations in the
nuclear localization signal (HA-ATF4ΔNLS) was constructed according to
Cibeli et al., 1999 (see also Materials and methods). The cytoplasmic
accumulation of HA-ATF4ΔNLS protein was clearly observed when
transfected into the neural tube (Supplemental Figure 3A), and neither
morphological changes of the neural tube nor a reduction of N-cadherin
expression was observed (Supplemental Figure 3B).
Fig. 3. Structural changes of ATF4-transfected trunk neural tube. (A) morphological changes of neural tubes and neuroepithelial cells by cotransfection of EGFP and HA-ATF4
misexpression, 6, 12, and 24 hours after electroporation. Compared to the EGFP-transfected control, ATF4 misexpression gradually causes degradation of the neural tube (left
columns). High-magniﬁcation views (middle and right columns) reveal that ATF4-transfected cells lose apicobasally elongated cell shape (see controls) and show round
morphology. Many transfected (arrowheads) and untransfected cells are found in the lumen of the neural tube 24 hours after ATF4-transfection. (B) Distribution of phospho-Histone
H3 (pH3)-positive mitotic cells, active caspase 3 (Cas3)-positive dying cells, and the basement membrane. While mitotic cells align along the apical lumen of the neural tube in the
control samples, at 12 and 24 hours after ATF4 transfection, transfected neural tubes possess mitotic cells in ectopic position (arrowheads). Cas3-positive cells are increased on the
transfected side (insets indicate the dorsal neural tube area) 12 and 24 hours after transfection. Anti-Laminin staining shows that, while ATF4 misexpression does not disrupt
basement membrane, ectopic deposition of Laminin is observed in the neural tube (higher magniﬁcation in the inset).
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that ATF4 might participate in neural crest EMT, but because
transfected cells failed to disrupt basement membrane and no
expression of neural crest marker HNK1 epitope was induced (Figs.
4C and R), ATF4 transfection did not seem to be sufﬁcient for neural
tube cells to acquire full neural crest identity. In fact, ATF4
misexpression rather reduced the basal level expression of HNK1
epitope in the neural tube (Fig. 4R).ATF4 function is required for the neural crest EMT and the following
dispersal
Next, we examined the requirement of ATF4 in the neural crest EMT.
Although an elevated expression of ATF4 mRNA was observed in the
neural folds ofmouse embryos (Murphy andKolstø, 2000), no noticeable
phenotype has been reported in the neural crest of ATF4-null mice
(Tanaka et al., 1998; Hettman et al., 2000; Masuoka and Townes, 2002;
Yang and Karsenty, 2004), suggesting that there might be functionally
Fig. 4. Effects of ATF4misexpression on expression of adhesion molecules in the trunk neural tube. Cotransfection of EGFP and HA-tagged ATF4 expression vectors. ATF4-transfected
cells does not show changes in N-cadherin protein (N-cad) expression 6 hours after electroporation (A and B), clear downregulation is observed 12 and 24 hours after transfection (F,
G, K, and L). Coincidently, expression of Sox2, an activator of N-cadherin transcription, is repressed (H and M). While ATF4misexpression upregulates expression of Cadherin7 (Cad7;
D, I, and N) and Integrin-β1 (ItgB1; E, J, and O), it downregulates Cadherin6B (Cad6B) expression (P and Q). Q, Q′, Q″ reveal downregulation of Cad6B in EGFP-positive ATF4-transfected
cells. ATF4 transfection does not induce HNK1 epitope expression (C and R) and rather represses basal expression of HNK1 (arrowhead in R) seen on the contralateral side.
663T. Suzuki et al. / Developmental Biology 344 (2010) 658–668redundant genes. We therefore took advantage of a dominant-negative
approach to interfere the function of endogenous ATF4. Thus, the N-
terminal transcriptional activation domain of ATF4 (Schoch et al., 2001)
was replaced with the repressor domain of Engrailed (En-ATF4ΔN, see
Fig. 5A). The dominant-negative effect of En-ATF4ΔN over wild type was
conﬁrmed by Luciferase assay with pCRE-luc reporter construct
(Supplemental Fig. 2, see also Materials and methods).
To observe the effect of En-ATF4ΔN transfection in vivo, this
construct was coelectroporated into the cranial neural folds of stage 6
embryos along with the EGFP expression vector. The transfected
embryos were allowed to develop for an additional 16 hours, and the
distribution of neural crest cells was assessed by the expression of
Sox10 (Figs. 5B–I). Sox10-positive neural crest cells were well
dispersed and reached to the prospective cranial anlagen, when
transfected only with EGFP (Figs. 5B–E). In contrast, En-ATF4ΔN-
transfected crest cells could not efﬁciently disperse (Figs. 5F–I). This
could have suggested that En-ATF4ΔN cell-autonomously interfered
the crest migration by altering the expression of cell–cell and cell–
ECM adhesion molecules, indicated by the misexpression studies
shown above. Alternatively, however, the transfection into the
epidermal ectoderm could have changed the migration pathway
environment by interfering ATF4 function in the epidermis.To exclude an indirect effect on EMT and migration and to observe
cellular changes by En-ATF4ΔN transfection, neural plate explants were
cotransfected with expression vectors of En-ATF4ΔN and EGFP, and
neural crest fate was induced by BMP4 treatment (Figs. 5J–W).
Explants were cultured for 20 hours, which was long enough to detect
many neural crest cells showing ﬁbroblastic morphology and
dispersing on the culture dish after EMT (Figs. 5L–N). When En-
ATF4ΔN was transfected, more than 50% of well-transfected explants
failed to adhere to the culture dish (Figs. 5J and K), suggesting a low
afﬁnity to ECM and a tight cell–cell adhesion. In the En-ATF4ΔN-
transfected explants successfully adhered to the culture dish, the
transfected cells tended to form aggregates and failed to disperse
(Figs. 5O–Q). While the EGFP-transfected cells possessed fragmented
anti-ZO-1 staining (Figs. 5R–T), the En-ATF4ΔN–transfected cells often
retained junctional complex, as revealed by anti-ZO-1 immunoreac-
tive meshwork (Figs. 5U–W, see also Fig. 5X for a measurement).
ATF4 promotes neural crest EMT in concert with other transcription
factors
A previous report revealed that combinatorial transfection of
transcription factor genes efﬁciently promote ectopic EMT of neural
tube cells, suggesting that the neural crest EMT may require a set of
Fig. 5.Dominant-negative ATF4 affects neural crest EMT andmigration. (A) Structure of dominant-negative ATF4. N-terminal activation domain is replacedwith Englailed2 repressor
domain (En). HA-tag is also added N-terminally. (B–I)Whole-mount preparations of embryos transfected with EGFP alone (B–E) or cotransfected with EGFP and En-ATF4ΔN (F–I) into
the ectoderm including the neural crest cells before the migration. While transfection of EGFP alone does not affect the distribution of Sox10-expressing cranial crest cells, Sox10-
positive crest cells fail to migrate effectively in the En-ATF4ΔN-transfected embryo (arrows in I), compared to the untransfected side (arrowheads in H). (J and K) BMP4-treated En-
ATF4ΔN-transfected neural plate explants that failed to adhere to the culture dish. BF: bright ﬁeld. (L–Q) BMP4-treated neural plate explants stained with phalloidin for F-actin and
DAPI for nuclei. While EGFP-transfected explant cells show ﬁbroblastic morphology and disperse on the culture dish (L–N), similar cells cotransfected with EGFP and En-ATF4ΔN fail to
disperse and form aggregates (O–Q). (R–W) BMP4-treated explants stained with anti-ZO-1 antibody for cell–cell junction and DAPI for nuclei. While explant cells transfected with
EGFP show fragmented ZO-1 immunoreactivity (R–T), En-ATF4ΔN-transfected explant cells retain meshwork-like cell–cell junction (U–W). (X) Counting ZO-1-stained rings/nucleus.
The number of ZO-1 ring was divided by the number of nuclei. More than 10 explants, more than 5000 cells were counted to obtain each value. Error bars indicate standard
deviations. Note: because the majority of En-ATF4ΔN-transfected explant cells form large cell aggregates, which makes cell count extremely difﬁcult, only portions of the explants
showing monolayers (see U–W) were subjected for counting. Thus, the obtained value of En-ATF4ΔN-transfected explants is likely an underestimation.
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also reviews mentioned above). Thus, misexpression of any single
transcription factor appeared to be insufﬁcient to induce “immediate”
EMT from the transfected neural tube in vivo, while simultaneous
cotransfection of a few was more effective (Cheung et al., 2005).
Because the phenotypes of ATF4 misexpression resembled that of
Foxd3, namely the repression of N-cadherin, the induction of Integrin-
β1, andmislocalization of Laminin protein (see Cheung et al., 2005), as
well as the repression of Cadherin6B (data not shown), wehypothesized that the cotransfection of Sox9 and ATF4, instead of
Foxd3, would effectively promote ectopic EMT. As a result, 24 hours
after transfection, the basal lamina was extensively disrupted, and
many transfected neural tube cells became HNK-1-positive and
migrated out of the neural tube, compared to the transfection of
ATF4 or Sox9 alone (Figs. 6A–I).
Our observations indicated above suggested an epistatic relation-
ship between ATF4 and Foxd3. Misexpression of Foxd3 failed to induce
ATF4 (Figs. 6M and N), although it induced Sox10 as reported
665T. Suzuki et al. / Developmental Biology 344 (2010) 658–668previously (data not shown, but see Cheung and Briscoe, 2003). In
contrast, ATF4 misexpression induced Foxd3 in the transfected neural
tube (Figs. 6K–L). These results indicated that ATF4 would be
epistatically upstream of Foxd3. ATF4 transfection did not affect the
endogenous expression of Sox9, Sox10, Snail2, Pax7, and Pax6 (data not
shown), indicating that ATF4 misexpression would affect neither the
neural crest induction nor the neural tube patterning.
Stability control is important for the neural crest-restricted rapid
elevation of ATF4 protein
Previous reports have indicated the importance of the stability
control of ATF4 protein in cultured cell lines (Lassot et al., 2001). InFig. 6. Relationship of ATF4 and other neural crest transcription factors. While
transfection of ATF4 or Sox9 does not results in ectopic EMT of transfected neural
tube cells in 24 hours (A–D), cotransfection of ATF4 and Sox9 results in a degradation of
the neural tube (G and H) and the disruption of the basal lamina (E and F), leading to
the delamination of transfected HNK-1-positive cells (E and F). Sox9 transfection
induces HNK-1 expression (C and D). (K–N) While Foxd3-transfection does not affect
the expression of ATF4 mRNA (M and N), ATF4-misexpression induces ectopic
expression of Foxd3 (K and L).fact, we have found that ATF4 protein weakly localized in the
cytoplasm of neural epithelial cells, and that, during the EMT, not only
ATF4 proteins accumulated in the nucleus, but also the protein levels
seemed signiﬁcantly upregulated. In contrast, ATF4mRNA expression
appeared to be relatively broad in the developing neural tube, and a
graded upregulation toward the dorsal neural folds was observed.
These data suggested the existence of posttranscriptional regulation
of ATF4 protein expression in the neural epithelium and the neural
crest.
β-TrCP1, a ligand-binding subunit of SCFβ -TrCP E3 ubiquitin ligase
complex, was shown to downregulate ATF4 protein expression by
ubiquitination leading to proteasomal degradation (Lassot et al.,
2001). To test if ATF4 protein level is regulated in avian neural crest,
neural plate explants were treated with MG132, a proteasome
inhibitor, and an increase of anti-ATF4 immunoreactivity was
observed (Fig. 7A). Next, we constructed an expression vector of
FLAG-tagged ATF4 with mutations in the β-TrCP1 binding sequence
(ATF4 D217A/S218A. see also Materials and methods). EGFP expression
vector was cotransfected either with FLAG-tagged wild type ATF4 or
ATF4 D217A/S218Amutant into the neural tube, and expression efﬁciency
was examined 16 hours after transfection (Figs. 7B and C). While
many EGFP-positive, FLAG-negative cells were detected when wild
type ATF4 was transfected, a drastic increase of EGFP/FLAG-double-
positive cells was observed when ATF4 D217A/S218A was transfected.
These results were further conﬁrmed by the use of dual promoter
vector (see Materials and methods), which ensured coexpression of
EGFP and FLAG-ATF4 (Fig. 7D). FLAG-ATF4 D217A/S218A seemed to be
fully active as transfected neural tubes showed a severe reduction of
N-cadherin expression and the neural tube degradation 24 hours after
transfection (Fig. 7E).
In a previous report, it was shown that p300 Histone acetyl-
transferase binds to the N-terminal region of ATF4 protein and
protects it from the β-TrCP-mediated degradation in HeLa and 293 T
cell lines (Lassot et al., 2005). Thus, we ﬁrst examined the expression
of p300 mRNA by in situ hybridization. p300 mRNA appeared to be
ubiquitously expressed in the early avian embryo, and no elevation
was found in the Snail2-positive neural crest cells (Figs. 8A and B).
However, p300 proteinwas highly accumulated in the nuclei of neural
crest cells, while fewer p300-positive cells were found in the rest of
the neural tube, and this protein distribution was similar to that of
ATF4 (Figs. 8C and D; see also above). Accordingly, to test if β-TrCP-
mediated degradation would contribute to the low levels of ATF4
protein expression in the neural tube, a p300 expression vector was
transfected into the neural tube. As a result, an ectopic upregulation of
endogenous ATF4 protein expression was detected in the neural tube
(Figs. 8E–G). These observations suggest that endogenous p300
protein might indeed stabilize ATF4 protein in the neural crest cells
undergoing EMT.
Discussion
ATF4, a new neural crest-related transcription factor
In this study, we have shown that ATF4 expression is upregulated
in neural crest cells and that ATF4 protein rapidly accumulates in the
nucleus during EMT, suggesting the involvement of ATF4 in the
control of neural crest EMT. Consistently, both misexpression and
dominant-negative expression studies indicated that ATF4 functions
for the promotion of crest EMT by regulating the expression of cell–
cell and cell–ECM adhesion molecules. Such functions of ATF4 can be
attributed to the transcriptional activation of downstream targets,
because ATF4ΔNLS showed no obvious phenotype when transfected
into the neural tube. While misexpression of group E Sox genes, such
as Sox9 and Sox10 takes 1.5–2 days for induction of ectopic EMT in the
neural tube (Cheung and Briscoe, 2003; Mckeown et al., 2005),
cotransfection of Sox9, Snail2, and Foxd3 (Cheung et al., 2005) or the
666 T. Suzuki et al. / Developmental Biology 344 (2010) 658–668combination of Sox9 and ATF4 (this study) efﬁciently induces ectopic
EMT from the neural tube in 24 hours. Our results therefore indicate
that ATF4 can substitute for Foxd3, likely by promoting Foxd3Fig. 7. Proteasomal degradation limits the level of ATF4 protein expression in the neural tub
express higher levels of ATF4 protein, compared to the explant cells treated with DMSO, the v
tube. Expression vectors of FLAG-tagged wild type ATF4 or ATF4 carrying mutations in the β-
tube, and expression of exogenous ATF4 protein expression is detected by anti-FLAG antib
S218A protein is nearly three times as effective as the wild type ATF4. (D) Cell counts using
than 500 EGFP-positive cells were examined in each embryo, and averaged proportions of FL
indicated for C and D. Error bars indicate standard deviation. (E) Misexpression of FLAG-ATF4
thinning (arrowheads) 24 hours after transfection.expression. These results are also in agreement with the relatively
late expression of both ATF4 protein (see above) and Foxd3 mRNA
(Sakai et al., 2006) in the crest cells undergoing EMT. It remains to bee and neural crest. (A) Proteasome inhibitor (MG132)-treated neural plate explant cells
ehicle of MG132. (B) Expression of exogenous, FLAG-tagged ATF4 proteins in the neural
TrCP1 binding site (FLAG-ATF4D217/S218A) are cotransfected with EGFP into the neural
ody 16 hours after transfection. (C) Cell counts of (B). Expression of FLAG-ATF4D217/
dual promoter vector pCMS-EGFP, ensuring coexpression of EGFP and FLAG-ATF4. More
AG–EGFP double-positive cells among EGFP-positive cells taken from three embryos are
D217/S218A causes a clear repression of N-cadherin expression and severe neural tube
Fig. 8. Expression and transfection of p300. (A and B) Transverse sections of stage
8 embryo. While Snail2 expression is highly restricted in the neural crest cells (B), p300
mRNA expression shows ubiquitous distribution (A). (C and D) Immunostaining
reveals restricted expression of p300 protein. p300-immunoreactivity is particularly
high in the premigratory neural crest cells at the hindbrain level of stage 9 embryo
(arrowhead in C), and at the trunk level of stage 11 embryo (arrowhead in D). (E–G)
Misexpression of p300 along with EGFP shows ectopic accumulation of endogenous
ATF4 protein in the transfected neural tube (open square brackets).
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for the initiation and/or maintenance of Foxd3 expression. Nonethe-
less, Foxd3 is probably one of the ATF4 target genes in the neural crest
EMT because the phenotype obtained by ATF4 misexpression in the
neural tube appears to be severer than that by Foxd3 misexpression
(compare studies by Dottori et al., 2001, Kos et al., 2001, and this
study) and because the inhibition of EMT of BMP4-treated neural
plate explants by En-ATF4ΔN could not be rescued by cotransfection of
Foxd3 (YW, unpublished data). While the apicobasally polarized
morphology of the neuroepithelial cells is maintained in the Foxd3-
transfected neural tube, ATF4-transfected cells round up and fall off
into the lumen of the neural tube. Such change in cell shape indicates
cytoarchitectural modiﬁcations along with cell polarity loss and
appears to be reminiscent of extensive cytoskeletal degradation and
remodeling during EMT.
It has been known that, while Foxd3 misexpression can induce
HNK1 in the neural tube (Kos et al., 2001; Dottori et al., 2001), ATF4
misexpression fails to do so. This can be explained, in part, by the fact
that Foxd3, but not ATF4, can induce Sox10 and that Sox10, in turn,
can induce HNK1 (McKeown et al., 2005; Suzuki et al., 2006). Indeed,
ATF4 misexpression rather downregulates the basal expression of
HNK1 epitope in the neural tube (see above). Therefore, ATF4-
mediated downregulation of HNK1 expression should be attenuated
in the crest cells. Because Sox9 misexpression in the neural tube
induces HNK1 no matter if ATF4 is cotransfected, Sox9 induction
appears to be important for the successful expression of HNK1 in the
neural crest.
Such complexity of the neural crest EMT regulatory network is also
observed in the regulation of Cadherin6B expression. A previous
report revealed that Snail2 represses Cadherin6B expression by a
direct binding around its promoter region (Taneyhill et al. 2007). In
this study, we show that ATF4 represses Cadherin6B expression,
probably by inducing Foxd3, without inducing Snail2. Thus, the tightregulation of Cadherin6B expression during the neural crest EMT is
achieved by the combination of transcription factors' activities.Stability control of ATF4 protein
While the importance of protein degradation/stability control in
development has been increasingly recognized in recent years, there
are only a few reports studying the role of protein degradation in
neural crest formation (Voigt and Papalopulu, 2005; Vernon and
LaBonne, 2006). For example, Cullin-1, the central scaffold compo-
nent of SCF E3 ubiquitin ligase complex, is important for the
allocation of neural crest domain in the ectoderm partly by
degradating β-catenin in Xenopus embryos (Voigt and Papalopulu,
2005). Their results seem to be consistent with the fact that β-
catenin is one of the target of SCFβTrCP-mediated ubiquitination
(Kitagawa et al., 1999). However, β-catenin is unlikely to be the only
target for degradation because SCF complexes will ubiquitinate a
wide range of proteins partly by using various F-box-containing
subunits, which determine the target speciﬁcity. In fact, a previous
report revealed that, in Xenopus, Ppa/Fbxl-14, an F-box-containing
subunit, bound and ubiquitinated Snail2 to limit its expression level
(Vernon and LaBonne, 2006). Except for these examples in Xenopus,
little attention has been paid to the role of the regulation of protein
stability in neural crest formation.
ATF4 has been known as an unstable protein, and serine
phosphorylation of DSGICMS sequence in ATF4 by an unknown
kinase promotes the binding of β-TrCP1 and subsequent ubiquitina-
tion and proteasomal degradation (Lassot et al., 2001). SCFβ-TrCP1–
mediated degradation has been proposed as the mechanism to
establish the tissue/cell type-restricted expression of ATF4 protein
(Yang and Karsenty, 2004). Yet, it has been unclear how such
degradation/stabilization is spatiotemporally controlled. As the
expression of β-TrCP1 and a related gene β-TrCP2 has been shown
to be regulated by Wnt signal in 293 T cells (Spiegelman et al., 2002),
and canonical Wnt signaling is involved in neural crest induction and
EMT promotion (García-Castro et al., 2002; Burstyn-Cohen et al.,
2004; see also reviewsmentioned above), it is reasonable to speculate
that the crest speciﬁc stabilization of ATF4 protein may be mediated
by the downregulation of β-TrCP1/2 transcription. However, β-TrCP1/
2 expression does not seem to be regulated in a neural crest-speciﬁc
manner (TS and YW, unpublished observation). Still, our mutation
analysis of the β-TrCP binding site revealed an effective expression of
ATF4 protein in the neural tube cells, suggesting that other
mechanisms should contribute the neural crest-speciﬁc stabilization
of ATF4 protein. In this study, we show that misexpression of p300 in
the neural tube increases the endogenous ATF4 protein expression.
Our data not only uncover the importance of β-TrCP-mediated
degradation to establish ATF4 expression speciﬁcity but also suggest
the involvement of p300 in this process. Consistently, endogenous
p300 protein level is remarkably high in pre-EMT crest cells,
compared to the rest of the neural tube cells. Coincidently, both
ATF4 and p300 proteins are highly expressed in the embryonic
epidermal ectoderm (see above), while the role of these proteins
there remains unknown. Yet, as p300mRNA is ubiquitously expressed,
posttranscriptional regulation of p300 expression in the neural crest
formation will have to be examined in the future. Nonetheless, our
current study emphasizes the importance of post-transcriptional
regulation of gene expression in formation of the neural crest. Our
inference in this study also well coincides with the recent ﬁndings
uncovering the importance of posttranscriptional control of tran-
scription factor expression in EMT, such as the degradation of Snail
protein facilitated by GSK3-β signaling and SCFβTrCP function (Zhou
et al., 2004) and the downregulation of ZEB-1/ZEB-2 expression by a
small noncoding RNA miR200 (Park et al., 2008; Gregory et al., 2008;
Korpal et al., 2008).
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